Elanco Animal Health ELAN 深 沪
等待开盘 01-13 09:30:00 美东时间
23.87
+0.400
+1.70%
华盛通- 最 高23.90
- 今 开23.52
- 成交量 464.91万股
- 最 低 23.28
- 昨 收 23.47
- 总市值 118.63亿
- 52周最高 23.90
- 市盈率 静 35.12
- 换手率 0.94%
- 52周最低 8.02
- 委 比 -17.96%
- 总股本 4.97亿
- 历史最高 37.61
- 量 比 1.02
- 振 幅 2.64%
- 历史最低 7.88
- 每 手 1
- 风险率 4.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股盘后 | 布朗保险经纪涨3.06%，Roivant Sciences Ltd Ordinary Shares涨2.60%
布朗保险经纪涨3.06%；Roivant Sciences Ltd Ordinary Shares涨2.60%；亚瑟加拉格尔涨1.94%
01-03 07:10
Elanco Animal Health Gets Approval For Befrena From U.S. Department of Agriculture To Treat Canine Allergic And Atopic Dermatitis
Elanco Animal Health Incorporated (NYSE:ELAN) today announced its latest entry into the rapidly growing canine dermatology space with the U.S. Department of Agriculture (USDA) approval of Befrena™ (tirnovetmab), a
01-01 03:02
美股盘后 | Elanco Animal Health涨1.73%，Revolution Medicines涨1.55%
Elanco Animal Health涨1.73%；Revolution Medicines涨1.55%；加拿大帝国商业银行涨1.52%
2025-12-27 07:10
ImmuCell Puts Re-Tain On Pause After FDA Letter
Animal health company ImmuCell receives an Incomplete Letter from the FDA for its Re-Tain NADA. Company shifts focus to First Defense.
2025-12-26 22:31
美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
2025-12-19 10:15
Jim Cramer Praises Elanco Animal Health: 'They've Turned That Company Around'
Cramer talks Elanco, Rocket Lab, Lithium Americas, Daktronics, M&T Bank and Ondas Holdings on the latest edition of Mad Money.
2025-12-18 21:02
美股盘后 | JBS N.V. Class A涨2.86%，百胜餐饮涨2.48%
JBS N.V. Class A涨2.86%；百胜餐饮涨2.48%；Silver Wheaton Corp.涨1.99%
2025-12-17 07:11
美股盘后 | Elanco Animal Health涨3.13%，Guardant Health涨2.66%
Elanco Animal Health涨3.13%；Guardant Health涨2.66%；加拿大皇家银行涨2.34%
2025-12-16 07:11
Chewy Outperforms In Tough Market, Though Industry Trends Signal Slower Rebound, Says Analyst
Chewy posts stronger customer metrics and Autoship gains, though Needham signals slow industry growth and pressure on the company's premium strategy.
2025-12-12 03:00
